Brain Lipids in Ageing and in Alzheimer's Disease: A Review

References

• Svennerholm L, Bostrom K, Helander CG. Membrane lipids in the ageing human brain. J Neurochem 1991; 56: 2051–9
   PubMed Web of Science ®Google Scholar
• Volicer L, Crino PB. Involvement of free radicals in dementia of the Alzheimer type: a hypothesis. Neurobiol Aging 1990; 11: 567–71
   PubMed Web of Science ®Google Scholar
• Sohal RS, Allen RG. Oxidative stress as a causal factor in differentiation and ageing: a unifying hypothesis. Exp Gerontol 1990; 25: 499–522
   PubMed Web of Science ®Google Scholar
• Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest 1982; 47: 412–26
   PubMed Web of Science ®Google Scholar
• Ceballos-Picot I, Trivier J-M, Nicole A. Age-correlated modifications of copper-zinc superoxide dismutase and glutathione-related enzyme activities in human erythrocytes. Clin Chem 1992; 38(66)70
   Google Scholar
• Matsubara LS, Machado PEA. Age-related changes of glutathione content, glutathione reductase and glutathione peroxidase activity of human erythrocytes. Braz J Med Biol Res 1991; 24: 449–54
   PubMed Web of Science ®Google Scholar
• Perrin R, Briancon S, Jeandel C. Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer's disease: a case control study. Gerontology 1990; 36: 306–13
   PubMed Web of Science ®Google Scholar
• Anneren G, Gardner A, Lundin T. Increased glutathione peroxidase activity in erythrocytes in patients with Alzheimer's disease/senile dementia of Alzheimer's type. Acta Neurol Scand 1986; 73: 586–9
   PubMed Web of Science ®Google Scholar
• Jeandel C, Nicolas MB, Dubois F. Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 1989; 35: 275–82
   PubMed Web of Science ®Google Scholar
• Benzi G, Pastoris O, Marzatico F. Cerebral enzyme antioxidant system. Influence of ageing and phosphatidylcholine. J Cereb Blood Flow Metab 1989; 9: 373–80
   PubMed Web of Science ®Google Scholar
• Vertechy M, Cooper MB, Ghirardi O. The effect of age on the activity of enzymes of peroxide metabolism in rat brain. Exp Gerontol 1993; 28: 77–85
   PubMed Web of Science ®Google Scholar
• Adams JD, Jr, Klaidman LK, Odunze IN. Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. Mol Chem Neuropathol 1991; 14: 213–26
   PubMedGoogle Scholar
• Subbarao KV, Richardson JS, Ang LC. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem 1990; 55: 342–5
   PubMed Web of Science ®Google Scholar
• Lang CA, Naryshkin S, Schneider DL. Low blood glutathione levels in healthy aging adults. J Lab Clin Med 1992; 120: 720–5
   PubMed Web of Science ®Google Scholar
• Levy DI, Sucher NJ, Lipton SA. Glutathione prevents N-methyl-d-aspartate receptor-mediated neurotoxicity. Neuro Report 1991; 2: 345–7
   PubMed Web of Science ®Google Scholar
• Burger PC, Vogel FS. The development of pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. Am J Pathol 1973; 73: 457–68
   PubMed Web of Science ®Google Scholar
• Oliver C, Holland AJ. Down's syndrome and Alzheimer's disease: a review. Psychol Med 1986; 16: 307–22
   PubMed Web of Science ®Google Scholar
• Vanella A, Geremia E, D'Urso G. Superoxide dismutase activities in ageing rat brain. Gerontology 1982; 28: 108–13
   PubMed Web of Science ®Google Scholar
• Zubenko GS, Sauer P. SOD-1 activity and platelet membrane fluidity in Alzheimer's disease. Biol Psychiatry 1989; 25: 671–8
   PubMed Web of Science ®Google Scholar
• Delacourte A, Defossez A, Ceballos I. Preferential localization of copper zinc superoxide dismutase in the vulnerable cortical neurons in Alzheimer's disease. Neuroscience Letters 1988; 92: 247–53
   PubMed Web of Science ®Google Scholar
• Pappolla MA, Omar RA, Kim KS, Robakis NK. Immunohistochemical evidence of antioxidant stress in Alzheimer's disease. Am J Pathol 1992; 140: 621–8
   PubMed Web of Science ®Google Scholar
• Marklund SL, Adolfsson R, Gottfries CG. Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type. J Neurol Sci 1985; 67: 319–25
   PubMed Web of Science ®Google Scholar
• Rodriguez-Martinez MA, Ruiz-Torres A. Homeostasis between lipid peroxidation and antioxidant enzyme activities in healthy human aging. Mech Ageing Dev 1992; 66: 213–22
   PubMed Web of Science ®Google Scholar
• Dowson JH, Fattoretti P, Carins M. The effects of ageing and a vitamin E-deficient diet on the lipopigment content of rat hippocampal and Purkinje neurones. Arch Gerontol Geriatr 1992; 14: 239–51
   PubMed Web of Science ®Google Scholar
• Noda Y, McGeer PL, McGeer EG. Lipid peroxides in brain during aging and vitamin E deficiency: possible relations to changes in neurotransmitter indices. Neurobiol Aging 1982; 3: 173–8
   PubMed Web of Science ®Google Scholar
• Ichitani Y, Okaichi H, Yoshikawa T. Learning behaviour in chronic vitamin E-deficient and supplemented rats: radial arm maze learning and passive avoidance response. Behav Brain Res 1992; 51: 157–64
   PubMed Web of Science ®Google Scholar
• Campbell D, Bunker VW, Thomas AJ. Selenium and vitamin E status of healthy and institutionalized elderly subjects: analysis of plasma, erythrocytes and platelets. Br J Nutr 1989; 62: 221–7
   PubMed Web of Science ®Google Scholar
• Zaman Z, Roche S, Fielden P. Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. Age Ageing 1992; 21: 91–4
   PubMed Web of Science ®Google Scholar
• Jackson CV, Holland AJ, Williams CA. Vitamin E and Alzheimer's disease in subjects with Down's Syndrome. J Ment Deficiency Res 1988; 32: 479–84
   PubMedGoogle Scholar
• Behl C, Davis J, Cole GM. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem Biophys Res Commun 1992; 186: 944–50
   PubMed Web of Science ®Google Scholar
• Miyamoto M, Murphy TH, Schnaar RL. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J Pharmacol Exp Ther 1989; 250: 1132–40
   PubMed Web of Science ®Google Scholar
• Patel M, Ardelt BK, Yim GKW. Interaction of trimethyltin with hippocampal glutamate. Neurotoxicology 1990; 11: 601–8
   PubMed Web of Science ®Google Scholar
• Bowry VW, Ingold KU, Stocker R. Vitamin E in human low-density lipoprotein. Biochem J 1992; 288: 341–4
   PubMed Web of Science ®Google Scholar
• Rotruck JT, Pope AL, Ganther HE. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973; 179: 588–90
   PubMed Web of Science ®Google Scholar
• McAlpine JK, Martin BJ, Lyon TDB. Selenium status of the elderly. J Clin Exp Gerontol 1988–89; 10: 149–55
   Web of Science ®Google Scholar
• Simonoff M, Conri C, Fleury B. Serum and erythrocyte selenium in normal and pathological states in France. Trace Elements in Medicine 1988; 5: 64–9
   Web of Science ®Google Scholar
• Kuroda M, Imura T, Morikawa K. Decreased serum levels of selenium and glutathione peroxidase activity associated with aging, malignancy and chronic hemodialysis. Trace Elements in Medicine 1988; 5: 97–103
   Web of Science ®Google Scholar
• Ward NI, Mason JA. Neutron activation analysis techniques for identifying elemental status in Alzheimer's disease. J Radioanalyt Nuclear Chem 1987; 113: 515–26
   Web of Science ®Google Scholar
• Corrigan FM, Reynolds GP, Ward NI. Reductions of zinc and selenium in brain in Alzheimer's disease. Trace Elements in Medicine 1991; 8: 1–5
   Google Scholar
• Corrigan FM, Reynolds GP, Ward NI. Hippocampal tin, aluminum and zinc in Alzheimer's disease. Bio Metals 1993; 6: 149–54
   Google Scholar
• Flodin NW. Pharmacology of Micronutrients. Alan R Liss, New York 1988
   Google Scholar
• Hullin RP. Serum zinc in psychiatric patients. In: Zinc Deficiency in Human Subjects. Alan R Liss, New York 1983; 197–206
   Google Scholar
• Van Rhijn AG, Corrigan FM, Ward NI. Serum aluminium in senile dementia of Alzheimer's type and in multi-infarct dementia. Trace Elements in Medicine 1989; 6: 24–6
   Google Scholar
• Constantinidis J. The hypothesis of zinc deficiency in the pathogenesis of neurofibrillary tangles. Med Hypotheses 1991; 35: 319–23
   PubMed Web of Science ®Google Scholar
• Aust SD, Morehouse LA, Thomas CE. Role of metals in oxygen radical reactions. J Free Radicals Biol Med 1985; 1: 3–25
   PubMedGoogle Scholar
• Jellinger K, Paulus W, Grundke-Iqbal I. Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J Neural Transm 1990; 2: 327–40
   Web of Science ®Google Scholar
• Connor IR, Menzies SL, St Martin SM. A histochemical study of iron, transferrin and ferritin in Alzheimer's diseased brains I. Neurosci Res 1992; 31: 75–83
   Web of Science ®Google Scholar
• Candy JM, Oakley AE, Watt F. A role for aluminium, silicon and iron in the genesis of senile plaques. Mod Trends Aging Res 1986; 147: 443–50
   Google Scholar
• Halliwell B, Gutteridge JMC. Aluminosilicates and Alzheimer's disease. Lancet 1986; i: 682
   Google Scholar
• Brayne C, Calloway P. Normal ageing, impaired cognitive function, and senile dementia of the Alzheimer's type: a continuum. Lancet 1988; i: 1265–6
   Google Scholar
• Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 1992; 42: 1681–8
   PubMed Web of Science ®Google Scholar
• Landsberg JP, McDonald B, Watt F. Absence of aluminium in neuritic plaque cores in Alzheimer's disease. Nature 1991; 360: 65–8
   Web of Science ®Google Scholar
• Jacobs RW, Duong T, Jones RE. A re-examination of aluminium in Alzheimer's disease: analysis by energy dispersive x-ray microprobe and flameless atomic absorption spectrophotometry. Can J Neurol Sci 1989; 16: 498–503
   PubMed Web of Science ®Google Scholar
• Gruca S, Wisniewski HM. Cytochemical study on the effect of aluminium on neuronal golgi apparatus and lysosomes. Acta Neuropathol 1984; 63: 287–95
   PubMed Web of Science ®Google Scholar
• Crapper DR, Karlik S, De Boni U. Aluminium and other metals in senile (Alzheimer) dementia. Aging 1978; 7: 471–85
   Google Scholar
• Schapira AHV, Cooper JM. Mitochondrial function in neurodegeneration and ageing. Mutat Res 1992; 275: 133–43
   PubMed Web of Science ®Google Scholar
• Langston JW, Irwin I. MPTP: current concepts and controversies. Clin Neuropharmacol 1986; 9: 485–507
   PubMed Web of Science ®Google Scholar
• Barbeau A, Roy M, Langston JW. Neurological consequence of industrial exposure of l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine. Lancet 1985; i: 747
   Google Scholar
• Smith MT, Sandy MS, Di Monte D. Free radicals, lipid peroxidation and Parkinson's disease. Lancet 1987; i: 38
   Google Scholar
• Schapira AHV, Cooper JM, Dexter D. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989; i: 1269
   Google Scholar
• Beal MF, Hyman BT, Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases. Trends Neurosci 1993; 16: 125–31
   PubMed Web of Science ®Google Scholar
• Sims NR, Finegan JM, Blass JP. Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res 1987; 436: 30–8
   PubMed Web of Science ®Google Scholar
• Burns A, Marsh A, Bender DA. Dietary intake and clinical, anthropometric and biochemical indices of malnutrition in elderly demented patients and non-demented subjects. Psychol Med 1989; 19: 383–91
   PubMed Web of Science ®Google Scholar
• Singh S, Mulley GP, Losowsky MS. Why are Alzheimer patients thin?. Age Aging 1988; 17: 21–8
   PubMed Web of Science ®Google Scholar
• Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?. Ann Neurol 1992; 31: 119–30
   PubMed Web of Science ®Google Scholar
• Trounce I, Byrne E, Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet 1989; i: 637–9
   Web of Science ®Google Scholar
• Cooper JM, Schapira AHV, Holt IJ. Biochemical and molecular aspects of human mitochondrial respiratory chain disorders. Biochem Soc Trans 1990; 18: 517–19
   PubMed Web of Science ®Google Scholar
• Parker WD, Jr, Filley CM, Parks JK. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 1990; 40: 1302–3
   PubMed Web of Science ®Google Scholar
• Kish SJ, Bergeron C, Rajput A. Brain cytochrome oxidase in Alzheimer's Disease. J Neurochem 1992; 59: 776–9
   PubMed Web of Science ®Google Scholar
• Cooper JM, Wischik C, Schapira AHV. Mitochondrial function in Alzheimer's disease. Lancet 1993; 341: 969–70
   PubMed Web of Science ®Google Scholar
• Lebel CP, Bondy SC. Persistent protein damage despite reduced oxygen radical formation in the aging rat brain. Int J Dev Neurosci 1991; 9: 139–46
   PubMed Web of Science ®Google Scholar
• Smith CD, Carney JM, Starke-Reed PE. Excess brain protein oxidation and enzyme dysfunction in normal ageing and in Alzheimer disease. Proc Natl Acad Sci USA 1991; 88: 10540–3
   PubMed Web of Science ®Google Scholar
• Stadtman ER. Protein oxidation and ageing. Science 1992; 257: 1220–4
   PubMed Web of Science ®Google Scholar
• Carney JM, Starke-Reed PE, Oliver CN. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-beta-phenylnitrone. Proc Natl Acad Sci USA 1991; 88: 3633–6
   PubMed Web of Science ®Google Scholar
• Brizzee KR, Ordy JM. Age pigments, cell loss and hippocampal function. Mech Ageing Dev 1979; 9: 143–62
   PubMed Web of Science ®Google Scholar
• Mann DMA, Yates PO, Stamp JE. The relationship between lipofuscin pigment and aging in the human nervous system. J Neurol Sci 1978; 37: 83–93
   PubMed Web of Science ®Google Scholar
• Katz ML, Stone WL, Dratz EA. Fluorescent pigment accumulation in retinal pigment epithelium of antioxidant-deflcient rats. Invest Ophthalmol Vis Sci 1978; 17: 1049–58
   PubMed Web of Science ®Google Scholar
• Begin ME, Ells G, Horrobin DF. Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J Nat Cancer Inst 1988; 80: 188–94
   PubMed Web of Science ®Google Scholar
• Dowson JH. Neuronal lipopigment: a marker for cognitive impairment and long-term effects of psychotropic drugs. Br J Psychiatry 1989; 155: 1–11
   PubMed Web of Science ®Google Scholar
• Dowson JH, Mountjoy CQ, Cairns MR. Change in intraneuronal lipopigment in Alzheimer's disease. Neurobiol Aging 1992; 13: 493–500
   PubMed Web of Science ®Google Scholar
• Cohen BM, Zubenko GS, Barr SM. Abnormal platelet membrane composition in Alzheimer's type dementia. Life Sci 1987; 40: 2445–51
   PubMed Web of Science ®Google Scholar
• Benowitz LI, Rodriguez W, Paskevich P. The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects. Exp Neurol 1989; 106: 237–50
   PubMed Web of Science ®Google Scholar
• Wainwright PE. Do essential fatty acids play a role in brain and behavioural development. Neurosci Biobehav Rev 1992; 16: 193–205
   PubMed Web of Science ®Google Scholar
• Tyurin VA, Tyurina YY, Avrova NF. Ganglioside-dependent factor, inhibiting lipid peroxidation in rat brain synaptosomes. Neurochem Int 1992; 20: 401–7
   PubMed Web of Science ®Google Scholar
• Soderberg M, Edlund C, Kristensson K. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 1991; 26: 421–4
   PubMed Web of Science ®Google Scholar
• Skinner ER, Watt C, Besson JAO. Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects. Brain 1993; 116: 717–25
   PubMed Web of Science ®Google Scholar
• Corrigan FM, Van Rhijn AG, Macintyre F. Dietary supplementation with zinc sulphate, sodium selenite and fatty acids in early dementia of Alzheimer's type II: effects on lipids. J Nutr Med 1991; 2: 265–71
   Google Scholar
• Corrigan FM, Gray RF, Strathdee A. Fatty acid analysis of blood from violent offenders. J Forensic Psychiatry 1994; 5: 84–92
   Google Scholar
• Bourre JM, Piciotti M, Dumont O. Delta-6-desaturase in brain and liver during development and ageing. Lipids 1990; 25: 354–6
   PubMed Web of Science ®Google Scholar
• Biagi PL, Bordoni A, Hrelia S. Gamma-Linolenic acid dietary supplementation can reverse the ageing influence on rat liver microsome delta-6-desaturase activity. Biochim Biophys Acta 1991; 1083: 187–92
   PubMedGoogle Scholar
• Suzuki H, Hayakawa S, Wada S. Effect of age on the modification of brain polyunsaturated fatty acids and enzyme activities by fish oil diet in rats. Mech Ageing Dev 1989; 50: 17–25
   PubMed Web of Science ®Google Scholar
• Petruzzella V, Baggetto LG, Penin F. In vivo effect of acetyl-1-carnitine on succinate oxidation, adenine nucleotide pool and lipid composition of synaptic and non-synaptic mitochrondria from cerebral hemispheres of senescent rats. Arch Gerontol Geriatr 1992; 14: 131–44
   PubMed Web of Science ®Google Scholar
• Wong KL, Murakami K, Routtenberg A. Dietary cis-fatty acids that increase protein Fl phosphorylation enhance spatial memory. Brain Res 1989; 505: 302–5
   PubMed Web of Science ®Google Scholar
• Linden DJ, Murakami K, Routtenberg A. A newly discovered protein kinase C activator (oleic acid) enhances long-term potentiation in the intact hippocampus. Brain Res 1986; 379: 358–63
   PubMed Web of Science ®Google Scholar
• Linden DJ, Sheu FS, Murakami K. Enhancement of long-term potentiation by cis-unsaturated fatty acid: relation to protein kinase C and phospholipase A2. J Neurosci 1987; 7: 3783–92
   PubMed Web of Science ®Google Scholar
• Shinitzky M, Inbar M. Difference in microviscosity induced by different cholesterol levels in the surface membrane lipid layer of normal lymphocytes and malignant lymphoma cells. J Mol Biol 1974; 85: 603–15
   PubMed Web of Science ®Google Scholar
• Zubenko GS, Huff FJ, Becker J. Cognitive function and platelet membrane fluidity in Alzheimer's disease. Biol Psychiatry 1988; 24: 925–36
   PubMed Web of Science ®Google Scholar
• Zubenko GS, Cohent BM, Growdon J. Cell membrane abnormality in Alzheimer's disease. Lancet 1984; ii: 235
   Google Scholar
• Van Rensburg SJ, Carstens ME, Potocnik FCV. Membrane fluidity of platelets and erythrocytes in patients with Alzheimer's disease and the effect of small amounts of aluminium on platelet and erythrocyte membranes. Neurochem Res 1991; 17: 825–9
   Web of Science ®Google Scholar
• Hajimohammadreza I, Brammer MJ, Eagger S. Platelet and erythrocyte membrane changes in Alzheimer's disease. Biochim Biophys Acta 1990; 1025: 208–14
   PubMed Web of Science ®Google Scholar
• Soderberg M, Edlund C, Alafuzoff I. Lipid compositions of different regions of the human brain during aging. J Neurochem 1990; 54: 415–23
   PubMed Web of Science ®Google Scholar
• Ruggiero FM, Cafagna F, Petruzzella V. Lipid composition in synaptic and nonsynaptic mitochrondria from rat brains and effect of aging. J Neurochem 1992; 59: 487–91
   PubMed Web of Science ®Google Scholar
• Soderberg M, Edlund C, Alafuzoff I. Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type. J Neurochem 1992; 59: 1646–53
   PubMed Web of Science ®Google Scholar
• Zubenko GS, Teply I. Longitudinal study of platelet membrane fluidity in Alzheimer's disease. Biol Psychiatry 1988; 24: 918–24
   PubMed Web of Science ®Google Scholar
• Kessler AR, Kessler B, Yehudu S. Changes in the cholesterol level, cholesterol-to-phospholipid mole ratio, and membrane lipid microviscosity in rat brain induced by age and a plant oil mixture. Biochem Pharmacol 1985; 34: 1120–1
   PubMed Web of Science ®Google Scholar
• Pande SV, Murthy MSR. Carnitine: vitamin for an insect, vital for man. Biochem Cell Biol 1989; 67: 671–3
   PubMed Web of Science ®Google Scholar
• Carta A, Calvani M. Acetyl-1-carnitine: a drug able to slow the progress of Alzheimer's disease. Ann N Y Acad Sci 1991; 640: 228–32
   PubMed Web of Science ®Google Scholar
• Angelucci L, Ramacci MT, Taglialatela G. Nerve growth factor binding in aged rat central nervous system: effect of acetyl-1-carnitine. J Neurosci Res 1988; 20: 491–6
   PubMed Web of Science ®Google Scholar
• De Simone R, Ramacci MT, Aloe L. Effect of acetyl-1-carnitine on forebrain cholinergic neurons of developing rats. Int J Dev Neurosci 1991; 9: 39–46
   PubMed Web of Science ®Google Scholar
• Nistico G, Ciriolo MR, Fiskin K. NGF restores decrease in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats. Free Radical Biol Med 1992; 12: 177–181
   PubMed Web of Science ®Google Scholar
• Arienti G, Ramacci MT, Maccari F. Acetyl-1-carnitine influences the fluidity of brain microsomes and of liposomes made of rat brain microsomal lipid extracts. Neurochem Res 1992; 17: 671–5
   PubMed Web of Science ®Google Scholar
• Bosman GJCGM, Bartholomeus IGP, De Man AJM. Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer's disease. Neurobiol Aging 1991; 12: 13–18
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Rangachari A. Acetylcarnitine increases membrane cytoskeletal protein-protein interactions. Life Sci 1992; 52: 297–303
   Web of Science ®Google Scholar
• Heaton-Ward WA. Mental Subnormality. John Wright and Sons, Bristol 1975
   Google Scholar
• Emerich DF, Walsh TJ. Ganglioside AGF2 promotes task-specific recovery and attenuates the cholinergic hypofunction induced by AF64A. Brain Res 1990; 527: 299–307
   PubMed Web of Science ®Google Scholar
• Emerich DW, Walsh TJ. Ganglioside AGF2 prevents the cognitive impairments and cholinergic cell loss following intraventricular colchicine. Exp Neurol 1991; 112: 328–37
   PubMed Web of Science ®Google Scholar
• Wallin A, Gottfries CG, Karlsson I. Decreased myelin lipids in Alzheimer's disease and vascular dementia. Acta Neurol Scand 1989; 80: 319–23
   PubMed Web of Science ®Google Scholar
• Pitsikas N, Algeri S. Deterioration of spatial and non-spatial reference and working memory in aged rats: protective effect of life-long calorie restriction. Neurobiol Aging 1992; 13: 369–73
   PubMed Web of Science ®Google Scholar
• Tacconi MT, Lligona L, Salmona M. Aging and food restriction: effect on lipids of cerebral cortex. Neurobiol Aging 1991; 12: 55–9
   PubMed Web of Science ®Google Scholar
• London ED, Waller SB, Ellis AT. Effects of intermittent feeding on neurochemical markers in aging rat brain. Neurobiol Aging 1985; 6: 199–204
   PubMed Web of Science ®Google Scholar
• Youngman LD, Park J-Y K, Ames BN. Protein oxidation associated with aging is reduced by dietary restriction of protein or calories. Proc Natl Acad Sci USA 1992; 89: 9112–16
   PubMed Web of Science ®Google Scholar
• Henderson AS, Jorm AF, Korten AE. Environmental risk factors for Alzheimer's disease: their relationship to age of onset and to familial or sporadic types. Psychol Med 1992; 22: 429–36
   PubMed Web of Science ®Google Scholar
• Uno H, Tarara R, Else JG. Hippocampal damage associated with prolonged and fatal stress in primates. J Neurosci 1989; 9: 1705–11
   PubMed Web of Science ®Google Scholar
• Sapolsky RM. Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels. J Neurosci 1986; 6: 2240–4
   PubMed Web of Science ®Google Scholar
• Kerr DS, Campbell LW, Applegate MD. Chronic stress-induced acceleration of electrophysiologic and morphometric biomarkers of hippocampal aging. J Neurosci 1991; 11: 1316–24
   PubMed Web of Science ®Google Scholar
• Sapolsky RM, Pulsinelli WA. Glucocorticoids potentiate ischemic injury to neurones: therapeutic implications. Science 1985; 229: 1397–9
   PubMed Web of Science ®Google Scholar
• Xie Y, Jones GS, Loring RH. Effects of oxidizing and reducing analogs of acetylcholine on neuronal nicotinic receptors. Mol Pharmacol 1992; 42: 356–63
   PubMed Web of Science ®Google Scholar
• Barrantes FJ. The lipid environment of the nicotinic acetylcholine receptor in native and reconstituted membranes. Crit Rev Biochem Mol Biol 1989; 24: 437–78
   PubMed Web of Science ®Google Scholar
• White P, Hiley CR, Goodhardt MJ. Neocortical cholinergic neurons in elderly people. Lancet 1977; i: 668–70
   Google Scholar
• Mountjoy CQ, Rossor MN, Iversen LL. Correlation of cortical cholinergic and gaba deficits with quantitative neuropathological findings in senile dementia. Brain 1984; 107: 507–18
   PubMed Web of Science ®Google Scholar
• Roberts GW. Immunocytochemistry of neurofibrillary tangles in dementia pugilistica and Alzheimer's disease: evidence for common genesis. Lancet 1988; ii: 1456
   Google Scholar
• Perry E. Acetylcholine and Alzheimer's disease. Br J Psychiatry 1988; 152: 731–40
   Web of Science ®Google Scholar
• Wurtman RJ. Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends Neurosci 1992; 15: 117
   PubMed Web of Science ®Google Scholar
• Vickers JC, Delacourte A, Morrison JH. Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease. Brain Res 1992; 594: 273–8
   PubMed Web of Science ®Google Scholar
• Vermersch P, Frigard B, David J-P. Presence of abnormally phosphorylated Tau proteins in the entorhinal cortex of aged non-demented subjects. Neurosci Letters 1992; 144: 143–6
   PubMed Web of Science ®Google Scholar
• Iversen SD. Recent advances in the anatomy and chemistry of the limbic system. Psychopharmacology of the Limbic System, MR Trimble, E Zarifian. Oxford University Press, Oxford 1985
   Google Scholar
• Emerich DF, Black BA, Kesslak JP. Transplantation of fetal cholinergic neurons into the hippocampus attenuates the cognitive and neurochemical deficits induced by AF64A. Brain Res Bull 1992; 28: 219–26
   PubMed Web of Science ®Google Scholar
• Stephenson DT, Podlisny MB, Games D. Effects of implants of beta amyloid protein in monkey cerebral cortex. Neurodegeneration 1992; 1: 177–87
   Google Scholar
• Sinha S, Lieberburg I. Normal metabolism of the amyloid precursor protein (APP). Neurodegeneration 1992; 1: 169–75
   Google Scholar
• Roberts GW, Gentleman SM, Lynch A. Beta A4 amyloid protein deposition in brain after head trauma. Lancet 1991; 338: 1422–3
   PubMed Web of Science ®Google Scholar
• Goate A, Chartier-Harlin M-C, Mullan M. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704
   PubMed Web of Science ®Google Scholar
• Chartier-Harlin M-C, Crawford F, Houlden H. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta amyloid precursor protein gene. Nature 1991; 353: 844
   PubMed Web of Science ®Google Scholar
• Kang J, Lemaire H-G, Unterbeck A. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325: 733
   PubMed Web of Science ®Google Scholar
• Nishimoto I, Okamoto T, Matsuura Y. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G0. Nature 1993; 362: 75–9
   PubMed Web of Science ®Google Scholar
• Nitsch RM, Slack BE, Wurtman RJ. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 1992; 258: 304–7
   PubMed Web of Science ®Google Scholar
• Fukuchi K-I, Sopher B, Martin GM. Neurotoxicity of beta amyloid. Nature 1993; 361: 122
   PubMed Web of Science ®Google Scholar
• Rooke K, Goate A, Fidani L. Screening of the promoter and the beta-amyloid sequence of the APP gene for polymorphism in families with late-onset Alzheimer's disease. Neurodegeneration 1992; 21: 237–40
   Google Scholar
• Seubert P, Oltersdorf T, Lee MG. Secretion of beta amyloid precursor protein cleaved at the amino terminus of the beta amyloid peptide. Nature 1993; 361: 260–3
   PubMed Web of Science ®Google Scholar
• Curatier P, Hugon J, Sindou P. Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors. Lancet 1993; 341: 265–8
   PubMed Web of Science ®Google Scholar
• Rosen DR, Siddique T, Patterson D. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59–62
   PubMed Web of Science ®Google Scholar
• Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992; 59: 1609–23
   PubMed Web of Science ®Google Scholar
• Pastuszko A, Wilson DF, Erecinska M. Effects of kainic acid in rat brain synaptosomes: the involvement of calcium. J Neurochem 1984; 43: 747–54
   PubMed Web of Science ®Google Scholar
• Palumbo EJ, Sweatt JD, Chen S-J. Oxidation-induced persistent activation of protein kinase C in hippocampal homogenates. Biochem Biophys Res Commun 1992; 187: 1439–45
   PubMedGoogle Scholar
• Chen L, Huang L-YM. Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 1992; 356: 521
   PubMed Web of Science ®Google Scholar
• Dykens JA, Stern A, Trenkner E. Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. J Neurochem 1987; 49: 1222–8
   PubMed Web of Science ®Google Scholar
• Pellegrini-Giampietro DE, Cherici G, Alesiani M. Excitatory amino acid release from rat hippocampal slices as a consequence of free-radical formation. J Neurochem 1988; 51: 19603–19603
   Web of Science ®Google Scholar
• Diedrich JF, Minnigan H, Carp RI. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 1991; 65: 4759–68
   PubMed Web of Science ®Google Scholar
• Wisniewski T, Golabek A, Matsubara E. Apolipoprotein E: binding to soluble Alzheimer's beta amyloid. Biochem Biophys Res Commun 1993; 192: 359–65
   PubMed Web of Science ®Google Scholar
• Strittmatter WJ, Saunders AM, Schmechel D. Apolipoprotein E: high-avidity binding to beta amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci 1993; 90: 197781–197781
   Web of Science ®Google Scholar
• Czech C, Monning U, Tienari PJ. Lancet 1993; 342: 1309–10
   PubMedGoogle Scholar
• Payami H, Kaye J, Heston LL. Apolipoprotein E gentoype and Alzheimer's disease. Lancet 1993; 342: 737–8
   Google Scholar
• Scott J. Apolipoprotein E and Alzheimer's disease. Lancet 1993; 342: 696
   PubMedGoogle Scholar
• Vericel E, Rey C, Calzada C. Age-related changes in arachidonic acid peroxidation and glutathione-peroxidase activity in human platelets. Prostaglandins 1992; 43: 75–85
   PubMed Web of Science ®Google Scholar
• Cand F, Verdetti J. Superoxide dismutase, glutathione peroxidase, catalase, and lipid peroxidation in the major organs of the ageing rats. Free Radical Biol Med 1989; 7: 59–63
   PubMed Web of Science ®Google Scholar
• Barja de Quiroga G, Perez-Campo R, Lopez Torres M. Antioxidant defences and peroxidation in liver and brain of aged rats. Biochem J 1990; 272: 247–50
   PubMed Web of Science ®Google Scholar
• Matsuo M, Gomi F, Dooley MM. Age-related alterations in antioxidant capacity and lipid peroxidation in brain, liver, and lung homogenates of normal and vitamin E-deficient rats. Mech Ageing Dev 1992; 64: 273–92
   PubMed Web of Science ®Google Scholar
• Ansari KA, Kaplan E, Shoeman D. Age-related changes in lipid peroxidation and protective enzymes in the central nervous system. Growth Dev Aging 1989; 53: 117–21
   PubMedGoogle Scholar
• De AK, Darad R. Age-associated changes in antioxidants and antioxidative enzymes in rats. Mech Ageing Dev 1991; 59: 123–8
   PubMed Web of Science ®Google Scholar
• Benzi G, Pastoris O, Marzatico F. The mitochondrial electron transfer alteration as a factor involved in brain ageing. Neurobiol Ageing 1992; 13: 361–8
   PubMed Web of Science ®Google Scholar
• Ravindranath V, Shivakumar BR, Anandatheerthavarada HK. Low glutathione levels in brain regions of aged rats. Neurosci Letters 1989; 101: 187–90
   PubMed Web of Science ®Google Scholar
• Kurobe N, Suzuki F, Kato K. Sensitive immunoassay of rat Cu/Zn superoxide dismutase: concentrations in the brain, liver, and kidney are not affected by aging. Biomed Res 1990; 11: 187–94
   Web of Science ®Google Scholar
• Semsei I, Rao G, Richardson A. Expression of superoxide dismutase and catalase in rat brain as a function of age. Mech Ageing Dev 1991; 58: 13–19
   PubMed Web of Science ®Google Scholar
• Muller DPR, Metcalfe T, Bowen DM. Vitamin E in brains of patients with Alzheimer's disease and Down's Syndrome. Lancet 1986; i: 1093–4
   Google Scholar
• Curti D, Giangare MC, Redolfi ME. Age-related modifications of cytrochrome c oxidase activity in discrete brain regions. Mech Ageing Dev 1990; 55: 171–80
   PubMed Web of Science ®Google Scholar
• Devasagayam TPA. Decreased peroxidative potential in rat brain microsomal fractions during ageing. Neurosci Letters 1989; 103: 92–6
   PubMed Web of Science ®Google Scholar
• Viani P, Cervato G, Fiorilli A. Age-related differences in synaptosomal peroxidative damage and membrane properties. J Neurochem 1991; 56: 253–8
   PubMed Web of Science ®Google Scholar
• Oliver CN, Levine RL, Stadtman ER. A role of mixed-function oxidation reactions in the accumulation of altered enzyme forms during aging. J Am Geriatr Soc 1987; 35: 947–56
   PubMed Web of Science ®Google Scholar
• Cabre E, Periago JL, Mingorance MD. Factors related to the plasma fatty acid profile in healthy subjects, with special reference to antioxidant micronutrient status: a multivariate analysis. Am J Clin Nutr 1992; 55: 831–7
   PubMed Web of Science ®Google Scholar
• Wortwein G, Stackman RW, Walsh TJ. Vitamin E prevents the place learning deficit and the cholinergic hypofunction induced by AF64A. Exp Neurol 1994; 125: 15–21
   PubMed Web of Science ®Google Scholar